CHICAGO — Neuroimmune modulation inhibited progression of structural damage in patients with rheumatoid arthritis who had inadequate response or intolerance […]
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had Epstein-Barr virus, according
Patients with eosinophilic granulomatosis with polyangiitis who received 2 years of treatment with the interleukin-5 inhibitor benralizumab exhibited durable remission
Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other factors,
Cognitive functional therapy sustains its long-term benefits in reducing activity limitations due to chronic low back pain over 3 years,
Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other
CHICAGO — A new program for training rheumatology fellows at Louisiana State University may offer a new way to combat
CHICAGO — Patients with systemic lupus erythematosus and diabetes who received sodium-glucose cotransporter 2 inhibitors exhibited decreased mortality rates but
“Deepfake doctors” present a threat to patient trust, medicine’s most valuable currency, and regulations must be implemented to protect public
CHICAGO — Approximately 43% of patients aged 65 years or older with rheumatic disease filled at least one opioid prescription
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to
CHICAGO — Direct-to-patient strategies may be more effective than broad campaigns at minimizing racial and ethnic disparities in lupus clinical
CHICAGO — The novel, oral tyrosine kinase 2 inhibitor deucravacitinib yielded durable ACR20 response rates through week 52 in patients
The American Osteopathic Association announced it has filed a lawsuit challenging an American Board of Internal Medicine policy which limits
CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive protein in
DALLAS — Blue Zones and the American College of Lifestyle Medicine developed a certification process designed to equip physicians with
It’s been nearly 1 year since Healio Community opened its proverbial doors to health care professionals looking to connect with
Financial stability and fostering unity to combat “division and chaos” are two top priorities for new American College of Rheumatology
Physician author Kevin J. Tracey, MD, discussed his book, The Great Nerve: The New Science of the Vagus Nerve and
CHICAGO — Cognitive errors, which can sometimes stem from “data overload,” can lead to misdiagnoses of complex rheumatic and autoimmune
CHICAGO — A previous diagnosis of a mental health disorder may predict neuropsychiatric complications in children with systemic lupus erythematosus,
CHICAGO — Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors had a lower risk for rheumatic disease vs.
CHICAGO — The novel B cell-targeting therapy ianalumab demonstrated improvement over placebo in key Sjögren’s disease parameters, according to data
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights how the lupus armamentarium
CHICAGO — Pregnant individuals with rheumatic diseases who were exposed to disease-modifying antirheumatic drugs did not experience severe morbidity, according
CHICAGO — Elevated levels of air pollution, specifically PM 2.5, may increase rheumatoid arthritis incidence rates and flares, according to
Health care providers can use social media to fight misinformation and rebuild trust in medicine, according to Dr. Mike.Mikhail O.
